The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1-(3,4-dichlorophenyl)-4,4-dimethyl-7-(2-methyloctan-2-yl)-1,4-dihydrochromeno[4,3-c]pyrazol-9-ol ID: ALA4483721
PubChem CID: 135936180
Max Phase: Preclinical
Molecular Formula: C27H32Cl2N2O2
Molecular Weight: 487.47
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: CCCCCCC(C)(C)c1cc(O)c2c(c1)OC(C)(C)c1cnn(-c3ccc(Cl)c(Cl)c3)c1-2
Standard InChI: InChI=1S/C27H32Cl2N2O2/c1-6-7-8-9-12-26(2,3)17-13-22(32)24-23(14-17)33-27(4,5)19-16-30-31(25(19)24)18-10-11-20(28)21(29)15-18/h10-11,13-16,32H,6-9,12H2,1-5H3
Standard InChI Key: AEDDUCGDZOJJSE-UHFFFAOYSA-N
Molfile:
RDKit 2D
33 36 0 0 0 0 0 0 0 0999 V2000
18.9151 -6.5251 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.5106 -5.8194 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.1017 -6.5226 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.5732 -6.1207 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9860 -5.4149 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.1684 -5.4104 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6912 -5.8194 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.3965 -4.5977 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.3949 -5.4131 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.0991 -5.8204 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8054 -5.4134 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8031 -4.5949 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.0983 -4.1913 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9899 -4.5955 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6912 -4.1850 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.5176 -3.3911 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.7088 -3.3109 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.3828 -4.0552 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.0963 -3.3742 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
19.2209 -5.4120 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.9290 -5.8199 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.6363 -5.4106 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.3444 -5.8185 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.0517 -5.4092 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.7598 -5.8171 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0613 -2.7840 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.8624 -2.9507 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.4054 -2.3410 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1485 -1.5644 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.3435 -1.4009 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8040 -2.0119 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0837 -0.6286 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
17.6909 -0.9531 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 1 0
5 4 1 0
6 5 1 0
14 5 1 0
5 7 1 0
7 9 1 0
8 15 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 8 1 0
14 15 2 0
15 16 1 0
16 17 1 0
17 18 2 0
18 14 1 0
13 19 1 0
11 2 1 0
2 20 1 0
20 21 1 0
21 22 1 0
22 23 1 0
23 24 1 0
24 25 1 0
26 27 2 0
27 28 1 0
28 29 2 0
29 30 1 0
30 31 2 0
31 26 1 0
16 26 1 0
30 32 1 0
29 33 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 487.47Molecular Weight (Monoisotopic): 486.1841AlogP: 8.43#Rotatable Bonds: 7Polar Surface Area: 47.28Molecular Species: NEUTRALHBA: 4HBD: 1#RO5 Violations: 1HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): 1CX Acidic pKa: 9.00CX Basic pKa: 0.91CX LogP: 8.59CX LogD: 8.58Aromatic Rings: 3Heavy Atoms: 33QED Weighted: 0.34Np Likeness Score: -0.27
References 1. Morales P, Gómez-Cañas M, Navarro G, Hurst DP, Carrillo-Salinas FJ, Lagartera L, Pazos R, Goya P, Reggio PH, Guaza C, Franco R, Fernández-Ruiz J, Jagerovic N.. (2016) Chromenopyrazole, a Versatile Cannabinoid Scaffold with in Vivo Activity in a Model of Multiple Sclerosis., 59 (14): [PMID:27309150 ] [10.1021/acs.jmedchem.6b00397 ]